Add BrightSurf on Google Email

Doctors and drug companies are still too cozy

A recent study in PLoS Medicine reveals that doctors' interactions with drug companies continue to influence prescribing practices, affecting quality and cost of care. The research suggests that these relationships can compromise the autonomy of medical professionals.

SourcePLOS·JournalPLOS Medicine·DateNov 2, 2010

eHealth evaluation needs alternate approach

Researchers critique the limitations of scientific approaches to eHealth evaluation, advocating for a new set of guiding principles. The authors argue that current methods are often flawed and fail to capture the complexities of healthcare in digital environments.

SourcePLOS·JournalPLOS Medicine·DateNov 2, 2010

Is team science productive?

Researchers at Penn Medicine measured the collaborative nature of translational medicine using network analysis, finding that ITMAT members' collaborative papers doubled since 2006. They also discovered that researchers were more likely to collaborate within their own departments and institutions rather than across them.

SourceUniversity of Pennsylvania School of Medicine·JournalScience Translational Medicine·DateOct 18, 2010

Researcher find fats galore in human plasma

A national research team led by UC San Diego scientists created the first lipidome of human plasma, discovering hundreds more fats than previously known. The findings reveal lipids' diverse roles beyond energy storage and cell membrane building, including signaling molecules that may play a role in diseases like diabetes and cancer.

SourceUniversity of California - San Diego·JournalJournal of Lipid Research·DateOct 14, 2010

Reviving the FDA: NEJM perspective

Georgetown University School of Medicine family medicine physician Susan Okie provides an overview of changes made by the FDA under Commissioner Margaret Hamburg. The FDA has adopted a more proactive approach to its public health mission, and is working to address growing pains within the agency.

SourceGeorgetown University Medical Center·JournalNew England Journal of Medicine·DateOct 6, 2010

Aeras-led research consortium receives FDA support

The Aeras Global TB Vaccine Foundation has received a $362,102 grant from the US FDA to develop new biological and immunological biomarkers for TB vaccine development. The project aims to evaluate four mycobacterial growth inhibition assays and identify T-cell immune responses associated with protective vaccines.

SourceAeras·DateOct 4, 2010

OU researchers selected by Navy

A University of Oklahoma research team will explore the biological stability of current and next-generation fuels, measuring their impact on biocorrosion activity. The five-year total grant aims to provide a scientific basis for assessing alternate fuels and mitigating fuel biodeterioration and biocorrosion problems.